CN1785959A - Preparation method of N,N-dimethyl-3-hydroxy-3-aryl propyl amine - Google Patents

Preparation method of N,N-dimethyl-3-hydroxy-3-aryl propyl amine Download PDF

Info

Publication number
CN1785959A
CN1785959A CN 200510122281 CN200510122281A CN1785959A CN 1785959 A CN1785959 A CN 1785959A CN 200510122281 CN200510122281 CN 200510122281 CN 200510122281 A CN200510122281 A CN 200510122281A CN 1785959 A CN1785959 A CN 1785959A
Authority
CN
China
Prior art keywords
dimethyl
solvent
reaction
oxo
arylprop
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510122281
Other languages
Chinese (zh)
Other versions
CN1304360C (en
Inventor
李爱军
刘东志
周雪琴
王健
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University
Original Assignee
Tianjin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University filed Critical Tianjin University
Priority to CNB2005101222819A priority Critical patent/CN1304360C/en
Publication of CN1785959A publication Critical patent/CN1785959A/en
Application granted granted Critical
Publication of CN1304360C publication Critical patent/CN1304360C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention discloses a preparation method of N,N-dimethyl-3-hydroxy-3-arylpropylamine. Said method includes the following steps: adding phenyl methyl ketone or 2-acetyl thiophenol and N,N-dimethylformamide dimethyl acetal into solvent including benzene and N,N-dimethylformamide, after the reaction is completed, evaporating solvent, cooling to obtain yellow crystal product, using solvent of ethyl acetate, etc, to make recrystallization and obtain N,N-dimethyl-3-oxo-3-aryl propyleneamine; adopting lithium aluminium hydride as reducing agent, adding N,N-dimethyl-3-oxo-3-aryl propyleneamine and reducing agent into the solvents of benzene, etc., making reaction to obtain product; or adopting sodium borohydride as reducing agent, adding N,N-dimethyl-3-oxo-3-aryl propyleneamine and reducing agent into solvents of acetic acid, etc., making reaction to obtain product; making said product undergo the process of phase separation, evaporating the organic phase obtained by means of phase separation so as to obtain N,N-dimethyl-3-hydrox-3-arylpropylamine.

Description

N, the preparation method of N-dimethyl-3-hydroxyl-3-aryl propyl amine
Technical field
The present invention relates to a kind of N, the preparation method of N-dimethyl-3-hydroxyl-3-aryl propyl amine belongs to the technology of preparing of the important intermediate of multiple antidepressant drug.
Background technology
N, N-dimethyl-3-hydroxyl-3-aryl propyl amine compounds is important pharmaceutical intermediate, can be used to medicines such as synthetic hydrochloric acid fluoxetine, tomoxetine hydrochloride, duloxetine hydrochloride.This class medicine has been widely used in the treatment of dysthymia disorders, has obtained general application in the whole world.Therefore lot of documents has been reported the synthetic method of relevant such intermediate.
N, N-dimethyl-3-hydroxyl-known preparation method's of 3-aryl propyl amine compounds example comprises: [US 4314081 in many patents, US 4194009, and EP 529842 etc.] in the synthetic of fluoxetine Hydrochloride described, important intermediate is N, N-dimethyl-3-hydroxyl-3-phenylpropylamine, it is a raw material with methyl phenyl ketone, Paraformaldehyde 96, Dimethylammonium chloride, in the presence of ethanol and hydrochloric acid, generate N by the Mannich reaction, N-dimethyl-3-oxo-3-phenylpropylamine then carries out reduction reaction with sodium borohydride and prepares in ethanol.
Gift comes the Weigel L. and co-worker [the Tetrahedron Letters thereof of company, Vol.31, No.49, pp 7101-7104,1990] and the Berglund R.A. of the said firm and co-worker thereof [US 5362886, US 5023269] reported the synthetic of duloxetine hydrochloride, important intermediate is N, N-dimethyl-3-hydroxyl-3-(2-thiophene phenyl) propylamine, it is with 2-acetyl thiophene phenol, Paraformaldehyde 96, Dimethylammonium chloride is a raw material, generate N by the Mannich reaction in the presence of ethanol or Virahol and hydrochloric acid, N-dimethyl-3-oxo-3-(2-thiophene phenyl) propylamine then carries out reduction reaction with sodium borohydride and prepares in ethanol.
But shortcomings such as the Mannich reaction yield is low, long reaction time, complicated operation that above-mentioned preparation method exists are therefore of crucial importance to the study on the synthesis of such intermediate.
Summary of the invention
The object of the present invention is to provide a kind of N, the preparation method of N-dimethyl-3-hydroxyl-3-aryl propyl amine, this method operating process is simple, is easy to industrialization.
The present invention is realized by following technical proposals, a kind of N, and the preparation method of N-dimethyl-3-hydroxyl-3-aryl propyl amine is characterized in that comprising following process;
1. synthetic N, N-dimethyl-3-oxo-3-arylprop enamine: with methyl phenyl ketone or 2-acetyl thiophene phenol and N, dinethylformamide dimethylacetal (DMFDMA) is 1 in molar ratio: 0.5-10 adds benzene, toluene, dimethylbenzene, chlorobenzene, pentane, hexane, hexanaphthene, heptane, ether, tetrahydrofuran (THF) diox, methyl alcohol, ethanol, Virahol, N, dinethylformamide or N, in the N-dimethylacetamide solvent, stir down 0-150 ℃ of reaction 1-10 hour, after reaction is finished, steam solvent, cooling obtains yellow crystalline product, use ethyl acetate, butylacetate, methylene dichloride, trichloromethane, tetracol phenixin, benzene, toluene or xylene solvent recrystallization, make N, N-dimethyl-3-oxo-3-arylprop enamine.
The reduction N, N-dimethyl-3-oxo-3-arylprop enamine prepares N, N-dimethyl-3-hydroxyl-3-aryl propyl amine:
The employing lithium aluminum hydride is a reductive agent, with N, N-dimethyl-3-oxo-3-arylprop enamine and reductive agent in molar ratio 1: 0.5-15 adds in benzene,toluene,xylene, chlorobenzene, pentane, hexane, hexanaphthene, heptane, ether, the tetrahydrofuran (THF) Huo diox solvent, stir down 0-150 ℃ of reaction 1-10 hour product; Or employing sodium borohydride, sodium cyanoborohydride, lithium borohydride or POTASSIUM BOROHYDRIDE are reductive agent, with N, N-dimethyl-3-oxo-3-arylprop enamine and reductive agent in molar ratio 1: 0.5-15 adds in the protic polar solvent of methyl alcohol, ethanol, formic acid, acetate, Monochloro Acetic Acid, dichloro acetic acid, methylsulfonic acid or tosic acid, stir down 0-150 ℃ of reaction 1-10 hour product; Reacted product is separated, and when using with water that the solvent of mixing is not made reaction solvent, adds water and makes and be separated; Use when doing reaction solvent with the solvent of water mixing, add and water the methylene chloride of mixing or chloroform be not to be separated, contained solvent steams in the organic phase that will obtain through being separated, and obtains N, N-dimethyl-3-hydroxyl-3-aryl propyl amine.
Above-mentioned methyl phenyl ketone or 2-acetyl thiophene phenol and N, dinethylformamide dimethylacetal are 1 in molar ratio: 1-4; Methyl phenyl ketone or 2-acetyl thiophene phenol and N, the solvent of dinethylformamide dimethylacetal reaction is N, dinethylformamide or N,N-dimethylacetamide or toluene; Methyl phenyl ketone or 2-acetyl thiophene phenol and N, the temperature of reaction of dinethylformamide dimethylacetal is 25-110 ℃; Recrystallization solvent is an ethyl acetate.
Above-mentioned reductive agent is lithium aluminum hydride, sodium borohydride or sodium cyanoborohydride; N, the mol ratio 1 of N-dimethyl-3-oxo-3-arylprop enamine and reductive agent: 1-4; The solvent that reduction is adopted is toluene or tetrahydrofuran (THF); The protic polar solvent is an acetate; Reduction reaction temperature is 25-100 ℃.
The invention has the advantages that its preparation process is simple, easy handling, the reaction times is short, yield is high, be easy to suitability for industrialized production.
Embodiment
Provide embodiment below illustrating in greater detail the present invention, but scope of the present invention is not limited to these embodiment.
Embodiment 1
Add 2-acetyl thiophene phenol (50.5g in the reaction flask, 0.4mol), DMFDMA (95.2g, 0.8mol) and N, dinethylformamide (250ml), be warming up to 100 ℃ of reactions 3 hours, decompression steams the solvent cooling and obtains yellow crystal, with ethyl acetate (400ml) recrystallization, obtains light yellow crystallization N, N-dimethyl-3-oxo-3-(2-thiophene phenyl) allylamine (67.4g, 92.1%).mp.117~119℃。MS?m/z:180.9,148.0,110.9,98.0,55.0,42.0。
Embodiment 2
Add lithium aluminum hydride (38g in the reaction flask, 1.0mol) and tetrahydrofuran (THF) (300ml), add N under the room temperature, and N-dimethyl-3-oxo-3-(2-thiophene phenyl) allylamine (36.2g, 0.2mol), finish, room temperature reaction 10 hours, cooling slowly adds entry (200ml) down, continue to stir 30 minutes, filter filtrate dichloromethane extraction (100ml * 3), drying, filter, steaming desolventizes and obtains light yellow thick oily matter N, N-dimethyl-3-hydroxyl-3-(2-thiophene phenyl) propylamine (33.5g, 82.4%), cooling curing obtains white solid, mp.70~73 ℃.MS?m/z:185.1,113.0,85.0,58.1,30.1。
Embodiment 3
Add methyl phenyl ketone (60.0 in the reaction flask, 0.5), DMFDMA (119g, 1.0mol) and N, dinethylformamide (300ml), be warming up to 100 ℃ of reactions 4 hours, decompression steams the solvent cooling and obtains yellow crystal, with ethyl acetate (450ml) recrystallization, obtains light yellow crystallization N, N-dimethyl-3-oxo-3-phenyl allylamine (78.9g, 90.1%).mp.93~94℃。MS?m/z:175.0,158.0,131.0,98.0,77.0,42.0。
Embodiment 4
(38g 1.0mol) and tetrahydrofuran (THF) (300ml), adds N under the room temperature to add lithium aluminum hydride in the reaction flask, (35g 0.2mol), finishes N-dimethyl-3-oxo-3-phenyl allylamine, room temperature reaction 12 hours, cooling slowly adds entry (200ml) down, continue to stir 30 minutes, filter filtrate dichloromethane extraction (100ml * 3), drying is filtered, and steams to desolventize to obtain light yellow thick oily matter N, N-dimethyl-3-hydroxyl-3-phenylpropylamine (29.3g, 81.8%).MS?m/z:179.1,105.0,77.0,58.1。
Embodiment 5
Add N in the reaction flask, N-dimethyl-3-oxo-3-phenyl allylamine (35g, 0.2mol), acetate (30g, 0.5mol) and benzene (300ml), stir and add sodium borohydride (7.6g down, 0.2mol), be warming up to 85 ℃ of reactions 3 hours, be cooled to room temperature, slowly add 10% sodium hydroxide solution (200ml), continue to stir 30 minutes, standing demix is told toluene liquid, washing (50ml * 3), drying is filtered, and steams to desolventize to obtain light yellow thick oily matter N, N-dimethyl-3-hydroxyl-3-phenylpropylamine (27.2g, 75.9%).MS?m/z:179.1,105.0,77.0,58.1。

Claims (3)

1. N, the preparation method of N-dimethyl-3-hydroxyl-3-aryl propyl amine is characterized in that comprising following process;
1) synthetic N, N-dimethyl-3-oxo-3-arylprop enamine: with methyl phenyl ketone or 2-acetyl thiophene phenol and N, the dinethylformamide dimethylacetal is 1 in molar ratio: 0.5-10 adds benzene, toluene, dimethylbenzene, chlorobenzene, pentane, hexane, hexanaphthene, heptane, ether, tetrahydrofuran (THF) diox, methyl alcohol, ethanol, Virahol, N, dinethylformamide or N, in the N-dimethylacetamide solvent, stir down 0-150 ℃ of reaction 1-10 hour, after reaction is finished, steam solvent, cooling obtains yellow crystalline product, use ethyl acetate, butylacetate, methylene dichloride, trichloromethane, tetracol phenixin, benzene, toluene or xylene solvent recrystallization, make N, N-dimethyl-3-oxo-3-arylprop enamine;
2) reduction N, N-dimethyl-3-oxo-3-arylprop enamine prepares N, N-dimethyl-3-hydroxyl-3-aryl propyl amine: the employing lithium aluminum hydride is a reductive agent, with N, N-dimethyl-3-oxo-3-arylprop enamine and reductive agent in molar ratio 1: 0.5-15 adds in benzene,toluene,xylene, chlorobenzene, pentane, hexane, hexanaphthene, heptane, ether, the tetrahydrofuran (THF) Huo diox solvent, stir down 0-150 ℃ of reaction 1-10 hour product; Or employing sodium borohydride, sodium cyanoborohydride, lithium borohydride or POTASSIUM BOROHYDRIDE are reductive agent, with N, N-dimethyl-3-oxo-3-arylprop enamine and reductive agent in molar ratio 1: 0.5-15 adds in the protic polar solvent of methyl alcohol, ethanol, formic acid, acetate, Monochloro Acetic Acid, dichloro acetic acid, methylsulfonic acid or tosic acid, stir down 0-150 ℃ of reaction 1-10 hour product; Reacted product is separated, and when using with water that the solvent of mixing is not made reaction solvent, adds water and makes and be separated; Use when doing reaction solvent with the solvent of water mixing, add and water the methylene chloride of mixing or chloroform be not to be separated, contained solvent steams in the organic phase that will obtain through being separated, and obtains N, N-dimethyl-3-hydroxyl-3-aryl propyl amine.
2. by the described N of claim 1, the preparation method of N-dimethyl-3-hydroxyl-3-aryl propyl amine is characterized in that, methyl phenyl ketone or 2-acetyl thiophene phenol and N, dinethylformamide dimethylacetal are 1 in molar ratio: 1-4; Methyl phenyl ketone or 2-acetyl thiophene phenol and N, the solvent of dinethylformamide dimethylacetal reaction is N, dinethylformamide or N,N-dimethylacetamide or toluene; Methyl phenyl ketone or 2-acetyl thiophene phenol and N, the temperature of reaction of dinethylformamide dimethylacetal is 25-110 ℃; Recrystallization solvent is an ethyl acetate.
3. by the described N of claim 1, the preparation method of N-dimethyl-3-hydroxyl-3-aryl propyl amine is characterized in that reductive agent is lithium aluminum hydride, sodium borohydride or sodium cyanoborohydride; N, the mol ratio 1 of N-dimethyl-3-oxo-3-arylprop enamine and reductive agent: 1-4; The solvent that reduction is adopted is toluene or tetrahydrofuran (THF); The protic polar solvent is an acetate; Reduction reaction temperature is 25-100 ℃.
CNB2005101222819A 2005-12-12 2005-12-12 Preparation method of N,N-dimethyl-3-hydroxy-3-aryl propyl amine Expired - Fee Related CN1304360C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005101222819A CN1304360C (en) 2005-12-12 2005-12-12 Preparation method of N,N-dimethyl-3-hydroxy-3-aryl propyl amine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005101222819A CN1304360C (en) 2005-12-12 2005-12-12 Preparation method of N,N-dimethyl-3-hydroxy-3-aryl propyl amine

Publications (2)

Publication Number Publication Date
CN1785959A true CN1785959A (en) 2006-06-14
CN1304360C CN1304360C (en) 2007-03-14

Family

ID=36783578

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005101222819A Expired - Fee Related CN1304360C (en) 2005-12-12 2005-12-12 Preparation method of N,N-dimethyl-3-hydroxy-3-aryl propyl amine

Country Status (1)

Country Link
CN (1) CN1304360C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101260062B (en) * 2008-04-18 2010-06-02 浙江工业大学 Method for synthesizing beta-aminopropenone compounds
CN108658930A (en) * 2018-07-11 2018-10-16 浙江工业大学 A kind of 2- acetyl thiophenes prepare the synthetic method of duloxetine hydrochloride key intermediate
CN110028486A (en) * 2019-04-28 2019-07-19 山东睿智医药科技有限公司 A kind of extracting method of duloxetine intermediate
CN114790146A (en) * 2022-05-19 2022-07-26 河南省科学院高新技术研究中心 Preparation method of 3- (methylamino) -1-aryl acetone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4194009A (en) * 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4956388A (en) * 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
US5362886A (en) * 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101260062B (en) * 2008-04-18 2010-06-02 浙江工业大学 Method for synthesizing beta-aminopropenone compounds
CN108658930A (en) * 2018-07-11 2018-10-16 浙江工业大学 A kind of 2- acetyl thiophenes prepare the synthetic method of duloxetine hydrochloride key intermediate
CN110028486A (en) * 2019-04-28 2019-07-19 山东睿智医药科技有限公司 A kind of extracting method of duloxetine intermediate
CN110028486B (en) * 2019-04-28 2021-10-29 山东睿智医药科技有限公司 Method for extracting duloxetine intermediate
CN114790146A (en) * 2022-05-19 2022-07-26 河南省科学院高新技术研究中心 Preparation method of 3- (methylamino) -1-aryl acetone
CN114790146B (en) * 2022-05-19 2024-03-29 河南省科学院高新技术研究中心 Preparation method of 3- (methylamino) -1-aryl acetone

Also Published As

Publication number Publication date
CN1304360C (en) 2007-03-14

Similar Documents

Publication Publication Date Title
KR100334585B1 (en) Asymmetric Synthesis
EP2114912B1 (en) Process for making duloxetine and related compounds
CN1304360C (en) Preparation method of N,N-dimethyl-3-hydroxy-3-aryl propyl amine
CN101607955A (en) A kind of preparation method of low-residue lipoic acid
CN101391991A (en) Method for preparing duloxetine
JP2005519077A (en) Production of N-methyl-3-hydroxy-3- (2-thienyl) propylamine via a novel thiophene derivative having a carbamate group as an intermediate
CN102229538B (en) Method for synthesizing dapoxetine
CN108947946B (en) Brain injury resistant deuterated compound and medical application thereof
CN103288630A (en) Synthesizing method of Salvianic acid A sodium
CN102070592B (en) Synthesis method of dihydroquercetin
CN101389621A (en) Process for the preparation of (s)-(-)-n,n-dimethyl-3-(2-thienyl)-3-hydroxypropanamine, a duloxetine intermediate
CN1837193A (en) Process for preparing diindolylmethane derivatives
CN108658930A (en) A kind of 2- acetyl thiophenes prepare the synthetic method of duloxetine hydrochloride key intermediate
CN106632233B (en) A kind of purification process preparing high-purity duloxetine hydrochloride intermediate
CN107235887A (en) A kind of polysubstituted diindolylmethane derivative and preparation method thereof
CN1817829A (en) Production of aryl-group-aryl biphenyl compound
CN101585829B (en) Resolution method of N-methyl Dutoxetine
CN102070602A (en) Process for synthesizing duloxetine hydrochloride
CN101012220A (en) Method of preparing N-methyl-3-hydroxy-3-(2-thiophene)propylamine
CN103551191B (en) Application of chiral amphiphilic block copolymer in chiral synthesis
CN1274692C (en) Total synthesizing meethod for pyrrole heterocyclic alkaloid aldisin
CN101003486B (en) Preparation method of chiral alicyclic amino-alcohol
CN103360365A (en) New preparation process of medicinal raw material duloxetine hydrochloride of antidepressant drug
CN1510024A (en) Compound for preparing citalopram enantiomer and its production
CN110117270B (en) Preparation method of 3- (thiophene-2-yl) cyclohexanone framework compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee